课题基金 / 基金详情

GRANULOCYTE EMIGRATION AND SEPTIC LUNG INJURY

GRANULOCYTE EMIGRATION AND SEPTIC LUNG INJURY
粒细胞迁移和脓毒性肺损伤
批准号:
3361616
负责人:
ROBERT K WINN
金额:
$8.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-04-01 至 1993-03-31

项目摘要

项目成果

ROBERT K WINN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project will investigate the mechanism of experimental septic lung injury with particular emphasis on the contribution of neurophil (PMN) adherence to endothelial cells. Experimental lung injury is used as a model of the adult respiratory distress syndrome in the United States with a mortality greater than 50% when it was first reported. Mortality had remained unchanged over the past 20 years. PMNs and their products in alveolar lavage fluid are hallmarks of ARDS and they have been implicated in causing experimental lung injury. The first specific aim will extensively characterize physiologic changes associated with three known cause of lung injury. The protocol used to produce injury have their origin in events that occur in trauma victims. In specific aims 2 and 3, rabbits will be treated with the monoclonal antibody (MAb) 60.3 at various times int he protocol developed is specific aim 1. The MAb 60.3 is directed to a functional epitope on the CD11/CD18 glycoprotein adherence complex on the PMNs and blocks CD18 dependent PMN adherence. The hypothesis of this proposal predict that PMNs are responsible for lung injury in models of sepsis. Further, they predict that PMNs form a protected microenvironment and blocking formation of that environment with anti-CD18 monoclonal antibodies will significantly reduce the injury. Treatment with ant-CD18 MAb will be effective in preventing lung injury since CD18 appeared to be in major mechanism of adherence in lung in response to live E. coli bacteria or E.coli endotoxin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Bcl-2 in Ischemia-Reperfusion Injury
  • 批准号:
    6740920
  • 项目类别:
  • 资助金额:
    $30.02万
  • 财政年份:
    2003
  • 负责人:
    ROBERT K WINN
  • 依托单位:
The Role of Bcl-2 in Ischemia-Reperfusion Injury
  • 批准号:
    6888303
  • 项目类别:
  • 资助金额:
    $30.02万
  • 财政年份:
    2003
  • 负责人:
    ROBERT K WINN
  • 依托单位:
The Role of Bcl-2 in Ischemia-Reperfusion Injury
  • 批准号:
    6611548
  • 项目类别:
  • 资助金额:
    $30.02万
  • 财政年份:
    2003
  • 负责人:
    ROBERT K WINN
  • 依托单位:
Bcl-2 induced protection in severe sepsis
  • 批准号:
    6820115
  • 项目类别:
  • 资助金额:
    $34.96万
  • 财政年份:
    2003
  • 负责人:
    ROBERT K WINN
  • 依托单位:
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: